Biotech & Healthtech Funding May–June 2026: ADCs, Immune Mapping, and AI Care
Anagram Therapeutics, Ona Therapeutics, IMU Biosciences, and Garner Health show biotech and healthtech capital in 2026 favoring validated science and AI-enabled care.
Venture Capital News, Guides & Fund Directory
Venture capital fuels the companies that reshape industries — from AI infrastructure and fintech to healthcare and defense tech. This hub collects our latest analysis on how VC firms evaluate startups, structure deals, and deploy capital across stages and geographies.
What You'll Find Here
- Fund profiles & directories: Stage focus, sector thesis, and check-size context for active investors
- Deal flow analysis: Funding roundups, mega-rounds, and emerging-manager activity
- Founder playbooks: Pitch decks, term sheets, warm intros, and fundraising strategy
- Market intelligence: Sector trends, valuation shifts, and LP allocation patterns
Browse the articles below to research investors, understand deal dynamics, and build a sharper fundraising strategy.
Related Articles (326 articles)
Climate & Energy Funding May–June 2026: Fusion, Grids, and the Physical Economy
Helion's $465M fusion round and Gigascale Capital's $250M fund show climate capital in 2026 favoring hard energy infrastructure with a path to cheaper, cleaner output.
Creator Fund's $56M: Backing Europe's Scientific Founders Early
Creator Fund closed $56M in June 2026 to back Europe's scientific and technical founders at the earliest stages — capital aimed at deeptech at the source.
Cybersecurity Funding May–June 2026: Cyera's $12B and the AI 'Trust Layer'
Cyera's $600M at a $12B valuation shows security capital in 2026 flowing to the 'trust layer' that governs what enterprise AI can access and do.
Cyera's $600M at $12B: Building the 'Trust Layer' for Enterprise AI
Cyera raised $600M at a $12B valuation in June 2026, quadrupling its worth in 18 months as the data-security platform governing what enterprise AI can access.
Fintech Funding May–June 2026: Ramp's $44B Leap and the AI Premium
Ramp's $750M at $44B, Corgi's stacked insurtech rounds, and India's Scapia show fintech is fundable again in 2026 — but only with a credible AI story.